BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24386393)

  • 1. Genetic heterogeneity of susceptibility gene in different ethnic populations: refining association study of PTPN22 for Graves' disease in a Chinese Han population.
    Xue L; Pan C; Gu Z; Zhao S; Han B; Liu W; Yang S; Yu S; Sun Y; Liang J; Gao G; Zhang X; Yuan G; Li C; Du W; Chen G; Chen J; Song H
    PLoS One; 2013; 8(12):e84514. PubMed ID: 24386393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves' disease in a Japanese population.
    Ichimura M; Kaku H; Fukutani T; Koga H; Mukai T; Miyake I; Yamada K; Koda Y; Hiromatsu Y
    Thyroid; 2008 Jun; 18(6):625-30. PubMed ID: 18578611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of PTPN22 polymorphism and its correlation with Graves' disease susceptibility in Polish adult population-A preliminary study.
    Wawrusiewicz-Kurylonek N; Koper-Lenkiewicz OM; Gościk J; Myśliwiec J; Pawłowski P; Krętowski AJ
    Mol Genet Genomic Med; 2019 Jun; 7(6):e661. PubMed ID: 30938100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dense mapping study of six European AITD susceptibility regions in a large Chinese Han Cohort of Graves' disease.
    Liu W; Zhang QY; Yuan FF; Wang HN; Zhang LL; Ma YR; Ye XP; Zhang MM; Song ZY; Li SX; Du WH; Liang J; Zhang XM; Gao GQ; Zhao SX; Chen FL; Song HD;
    Clin Endocrinol (Oxf); 2018 Dec; 89(6):840-848. PubMed ID: 30176063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in the ADRB2 gene and Graves disease: a case-control study and a meta-analysis of available evidence.
    Chu X; Dong Y; Shen M; Sun L; Dong C; Wang Y; Wang B; Zhang K; Hua Q; Xu S; Huang W
    BMC Med Genet; 2009 Mar; 10():26. PubMed ID: 19284637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease.
    Gu LQ; Zhu W; Zhao SX; Zhao L; Zhang MJ; Cui B; Song HD; Ning G; Zhao YJ
    Clin Endocrinol (Oxf); 2010 Feb; 72(2):248-55. PubMed ID: 19438904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the CTLA4 gene with Graves' disease in the Chinese Han population.
    Zhao SX; Pan CM; Cao HM; Han B; Shi JY; Liang J; Gao GQ; Peng YD; Su Q; Chen JL; Zhao JJ; Song HD
    PLoS One; 2010 Mar; 5(3):e9821. PubMed ID: 20352109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic study of early-onset Graves' disease in the Chinese Han population.
    Yuan FF; Ye XP; Liu W; Xue LQ; Ma YR; Zhang LL; Zhang MM; Sun F; Wan YY; Zhang QY; Zhao SX; Song HD;
    Clin Genet; 2018 Jan; 93(1):103-110. PubMed ID: 28598035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PTPN22 R263Q polymorphism confers protection against systemic lupus erythematosus and rheumatoid arthritis, while PTPN22 R620W confers susceptibility to Graves' disease in a Mexican population.
    López-Cano DJ; Cadena-Sandoval D; Beltrán-Ramírez O; Barbosa-Cobos RE; Sánchez-Muñoz F; Amezcua-Guerra LM; Juárez-Vicuña Y; Aguilera-Cartas MC; Moreno J; Bautista-Olvera J; Valencia-Pacheco G; López-Villanueva RF; Ramírez-Bello J
    Inflamm Res; 2017 Sep; 66(9):775-781. PubMed ID: 28500376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A variant within intron 1 of the PTPN22 gene decreases the genetic susceptibility of ankylosing spondylitis in a central south Chinese Han population.
    Tang L; Wang Y; Chen BF
    Scand J Rheumatol; 2014; 43(5):380-4. PubMed ID: 24749936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic association of Fc receptor-like glycoprotein with susceptibility to Graves' disease in a Chinese Han population.
    Fang Y; Li Y; Zeng J; Wang J; Liu R; Cao C
    Immunobiology; 2016 Jan; 221(1):56-62. PubMed ID: 26321232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset.
    Skórka A; Bednarczuk T; Bar-Andziak E; Nauman J; Ploski R
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):679-82. PubMed ID: 15943829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association of polymorphism of protein tyrosine phosphatase nonreceptor-22 gene with AITD].
    Yu ZY; Zhang JA; Maier HB; Wang Y; Xiao WX; Quan Y; Dong BN
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Aug; 24(8):804-7. PubMed ID: 18687223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between CTLA-4 and CD40 gene polymorphisms and their interaction in graves' disease in a Chinese Han population.
    Chen X; Hu Z; Liu M; Li H; Liang C; Li W; Bao L; Chen M; Wu G
    BMC Med Genet; 2018 Sep; 19(1):171. PubMed ID: 30223781
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Zhang M; Liu S; Xu J; Lv S; Fan Y; Zhang Y; Zhang Y; Wu Y; Su Y; Yu H; Song S; He J; Li H
    Curr Eye Res; 2020 Jul; 45(7):888-895. PubMed ID: 31869260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the protein tyrosine phosphatase nonreceptor 22 haplotypes with autoimmune thyroid disease in the Japanese population.
    Ban Y; Tozaki T; Taniyama M; Nakano Y; Ban Y; Ban Y; Hirano T
    Thyroid; 2010 Aug; 20(8):893-9. PubMed ID: 20615141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of PTPN22 1858T/T genotype with type 1 diabetes, Graves' disease but not with rheumatoid arthritis in Russian population.
    Zhebrun D; Kudryashova Y; Babenko A; Maslyansky A; Kunitskaya N; Popcova D; Klushina A; Grineva E; Kostareva A; Shlyakhto E
    Aging (Albany NY); 2011 Apr; 3(4):368-73. PubMed ID: 21467606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT60 single nucleotide polymorphism of the CTLA-4 gene is associated with susceptibility to Graves' disease in the Taiwanese population.
    Weng YC; Wu MJ; Lin WS
    Ann Clin Lab Sci; 2005; 35(3):259-64. PubMed ID: 16081581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predisposition to Graves' disease and Graves' ophthalmopathy by genetic variants of IL2RA.
    Du J; Wang X; Tan G; Wei W; Zhou F; Liang Z; Li H; Yu H
    J Mol Med (Berl); 2021 Oct; 99(10):1487-1495. PubMed ID: 34287665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refined association of TSH receptor susceptibility locus to Graves' disease in the Chinese Han population.
    Liu BL; Yang SY; Liu W; Xue LQ; Chen X; Pan CM; Gu ZH; Zhan M; Zhang XM; Liang J; Gao GQ; Du WH; Yuan GY; Ying R; Zhao SX; Song HD
    Eur J Endocrinol; 2014 Jan; 170(1):109-19. PubMed ID: 24144966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.